Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.76 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | MEN1 | O00255 | 6/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.76 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.76 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.76 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.76 |
| ▸ | FLT3 | P36888 | 5/20 | 0.76 |
| ▸ | MAOB | P27338 | 5/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.76 |
| ▸ | HPGD | P15428 | 4/20 | 0.76 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 0.76 |
| ▸ | SLCO2B1 | O94956 | 4/20 | 0.76 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.76 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.76 |
| ▸ | GABRP | O00591 | 4/20 | 0.76 |
| ▸ | GABRD | O14764 | 4/20 | 0.76 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13237064 | 0.87 | POLH (0.74) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL29351464 | 0.86 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL5083245 | 0.86 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL19428 | 0.86 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL29872582 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL31168790 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL29968480 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL31477961 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL30544810 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 | |
| Apigenin SCHEMBL1658882 | 0.85 | KMT2A (0.97) | KMT2AMAPTMEN1CYP3A4ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759317-B2 | Analgesic and anti-inflammatory compositions and methods with flavonoid glycoside-type compounds | BMB PATENT HOLDING CORPORATION (US) | 2010-07-20 | — | — | US | disclosed |
| US-7759317-B2 | Analgesic and anti-inflammatory compositions and methods with flavonoid glycoside-type compounds | BMB PATENT HOLDING CORPORATION (US) | 2010-07-20 | — | — | US | disclosed |
| US-20080171708-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS WITH FLAVONOID GLYCOSIDE-TYPE COMPOUNDS | BMB PATENT HOLDING CORPORATION (US) | 2008-07-17 | — | — | US | disclosed |
| US-20080171708-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS WITH FLAVONOID GLYCOSIDE-TYPE COMPOUNDS | BMB PATENT HOLDING CORPORATION (US) | 2008-07-17 | — | — | US | disclosed |
| WO-2008083332-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS WITH FLAVONOID GLYCOSIDE -TYPE COMPOUNDS | BMB PATENT HOLDING CORPORATION (US) | 2008-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171708-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS WITH FLAVONOID GLYCOSIDE-TYPE COMPOUNDS | PTGS1, PTGS2, PTGES | KMT2A 3824/4885MAPT 3386/4885MEN1 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.